Exane Derivatives’s GGP Inc. GGP Stock Holding History

Exane Derivatives’s Portfolio GGP Stock Details GGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-93	Closed	-$1.91K	–	736
2018 Q2	$1.91K	Buy	93 +12	+15%	+$243	﹤0.01%	500
2018 Q1	$1.67K	Sell	81 -14	-15%	-$310	﹤0.01%	458
2017 Q4	$2.22K	Sell	95 -283	-75%	-$6.3K	﹤0.01%	451
2017 Q3	$7.85K	Buy	378 +17	+5%	+$372	﹤0.01%	413
2017 Q2	$8.5K	Buy	361 +28	+8%	+$645	﹤0.01%	404
2017 Q1	$7.72K	Buy	333 +3	+0.9%	+$73	﹤0.01%	363
2016 Q4	$8.24K	Buy	330 +37	+13%	+$946	﹤0.01%	412
2016 Q3	$8.09K	Hold	293	–	–	﹤0.01%	422
2016 Q2	$8.74K	Sell	293 -5	-2%	-$141	﹤0.01%	379
2016 Q1	$8.86K	Hold	298	–	–	﹤0.01%	419
2015 Q4	$8.11K	Hold	298	–	–	﹤0.01%	344
2015 Q3	$7.74K	Buy	298 +9	+3%	+$236	﹤0.01%	366
2015 Q2	$7.42K	Hold	289	–	–	﹤0.01%	379
2015 Q1	$8.54K	Sell	289 -726	-72%	-$21.7K	﹤0.01%	386
2014 Q4	$28.5K	Buy	+1,015	New	+$26.4K	﹤0.01%	358

Other funds holding GGP

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Exane Derivatives's GGP Position: Q3 2018 in Review

Exane Derivatives sold out of GGP Inc. (GGP) in Q3 2018, closing a stake of 93 shares — an estimated $1.91K sold.

Exane Derivatives first reported a position in GGP in Q4 2014 and held it in 15 quarters. The position peaked at $28.5K in Q4 2014. 1 fund tracked by Wall St. Rank holds GGP as of Q3 2018.

Exane Derivatives reported no remaining GGP Inc. position as of Q3 2018 after selling out during the quarter.
Exane Derivatives sold 93 GGP Inc. shares in Q3 2018, an estimated $1.91K.
Exane Derivatives first reported a position in GGP Inc. in Q4 2014 and held it in 15 quarters.
Exane Derivatives's GGP Inc. position peaked at $28.5K in Q4 2014.
1 fund tracked by Wall St. Rank held GGP Inc. as of Q3 2018.

Based on Exane Derivatives's 13F filing for Q3 2018, filed 24 Oct 2018.